Elutia ELUT
NASDAQ ELUT
$0.82 +0.02 (+2.50%)
As of: Oct 2, 2026 · 1:09 PM EDT

Elutia (ELUT) Non-Current Deffered Revenue (2019 - 2021)

Updated

Elutia's Non-Current Deffered Revenue was $936,000 in Q3 2021, up 77.6% from $527,000 a year earlier and up 7.6% from the prior quarter.

Analysis

Elutia (ELUT) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends

At the end of FY2020, Non-Current Deffered Revenue at Elutia came in at $756,000, up 7.2% from FY2019.

  • In earlier years, Non-Current Deffered Revenue was $705,000 in FY2019.
  • Per Business Quant data, ELUT's Non-Current Deffered Revenue in the three quarters before Q3 2021 was $870,000 (Q2 2021), $830,000 (Q1 2021) and $756,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Elutia 34.99 Mn -54.47 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 936,000.00
Jun 30, 2021 870,000.00
Mar 31, 2021 830,000.00
Dec 31, 2020 756,000.00
Sep 30, 2020 527,000.00
Dec 31, 2019 705,000.00
API Access

Elutia Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ELUT&period=max&api_key=YOUR_API_KEY